Event time: 事件时间：
Published: 文章发布：
BMY clinical outcome: Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary EndpointBristol-Myers Squibb Company（BMY）披露关键临床试验达到主要终点
BMY clinical outcome: Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary Endpoint.
Bristol-Myers Squibb Company（BMY）披露关键临床试验达到主要终点。
For information only. Not investment advice.内容仅供参考，不构成投资建议。